Home » Newsletters » BioWorld Science

BioWorld Science

April 16, 1998

View Archived Issues

Benefits of abciximab therapy in coronary stent deployment and coronary angioplasty

American Biogenetic Sciences and Trevigen sign agreement

Progenitor discovers first protein lipase gene expressed in endothelial tissue

New class of adenosine antagonists prepared at Boehringer Ingelheim

Ono claims iNOS inhibitors

Propionanilide derivatives for lipoprotein disorders discovered at Yamanouchi

CRF antagonists for stress-related disorders from DuPont Merck

Algos: Q4 and year-end 1997 highlights

ImClone Systems: Q4 and year-end 1997 highlights

Beta-lactamase inhibitors available for licensing from RCT

NeuroSearch receives FDA approval to begin phase II trial with NS-2710

Nortran's anesthetic RSD-921 nears phase II trials in Malaysia

Titan: Q4 and year-end 1997 highlights

Pentose begins phase I/II trials of PEN-203

Antitumor illudin analogues discovered at U. of California

Kynurenine 3-monooxygenase inhibitors under study at P&U as neuroprotectants

Sanofi discloses phenoxypropanolamines as beta3-adrenoceptor antagonists

NeoTherapeutics: Q4 and FY 1997 highlights

Pfizer announces Viagra market introduction

Alliance receives additional patent coverage for ultrasound contrast agents

New approach to TB vaccination described by Merck

Genentech claims TF-FVIIa hybrids for coagulation disorders

New anti-HSV agents synthesized in Taiwan

Kyowa Hakko reports antitumor antibiotic UCH15B at Japanese meeting

AvMax's essential oils improve oral bioavailability of therapeutic agents

ADCON-L is approvable, FDA says

Cosopt receives marketing approval from FDA

Baxter acquires Ohmeda's pharmaceutical products division

Meiji Seika presents 5-HT7 antagonist DR-4004

DuPont Merck presents a novel CRF-R1 antagonist for anxiety and depression

Novel TK inhibitors with immunosuppressant activity reported by R.W. Johnson

Another H3 antagonist in the pipeline at Gliatech

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...